Literature DB >> 9174094

Splicing of a divergent subclass of AT-AC introns requires the major spliceosomal snRNAs.

Q Wu1, A R Krainer.   

Abstract

AT-AC introns constitute a minor class of eukaryotic pre-mRNA introns, characterized by 5'-AT and AC-3' boundaries, in contrast to the 5'-GT and AG-3' boundaries of the much more prevalent conventional introns. In addition to the AT-AC borders, most known AT-AC introns have highly conserved 5' splice site and branch site sequence elements of 7-8 nt. Intron 6 of the nucleolar P120 gene and intron 2 of the SCN4A voltage-gated skeletal muscle sodium channel are AT-AC introns that have been shown recently to be processed via a unique splicing pathway involving several minor U snRNAs. Interestingly, intron 21 of the same SCN4A gene and the corresponding intron 25 of the SCN5A cardiac muscle sodium channel gene also have 5'-AT and AC-3' boundaries, but they have divergent 5' splice site and presumptive branch site sequences. Here, we report the accurate in vitro processing of these two divergent AT-AC introns and show that they belong to a functionally distinct subclass of AT-AC introns. Splicing of these introns does not require U12, U4atac, and U6atac snRNAs, but instead requires the major spliceosomal snRNAs U1, U2, U4, U5, and U6. Previous studies showed that G --> A mutation at the first position and G --> C mutation at the last position of a conventional yeast or mammalian GT-AG intron suppress each other in vivo, suggesting that the first and last bases participate in an essential non-Watson-Crick interaction. Our results show that such introns, hereafter termed AT-AC II introns, occur naturally and are spliced by a mechanism distinct from that responsible for processing of the apparently more common AT-AC I introns.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174094      PMCID: PMC1369508     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  27 in total

1.  Role of the 3' splice site in U12-dependent intron splicing.

Authors:  R C Dietrich; M J Peris; A S Seyboldt; R A Padgett
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway.

Authors:  M L Hastings; A R Krainer
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

Review 3.  AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes.

Authors:  Q Wu; A R Krainer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  A mutational analysis of U12-dependent splice site dinucleotides.

Authors:  Rosemary C Dietrich; John D Fuller; Richard A Padgett
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

5.  Base pairing with U6atac snRNA is required for 5' splice site activation of U12-dependent introns in vivo.

Authors:  R Incorvaia; R A Padgett
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

6.  An Rtf2 Domain-Containing Protein Influences Pre-mRNA Splicing and Is Essential for Embryonic Development in Arabidopsis thaliana.

Authors:  Taku Sasaki; Tatsuo Kanno; Shih-Chieh Liang; Pao-Yang Chen; Wen-Wei Liao; Wen-Dar Lin; Antonius J M Matzke; Marjori Matzke
Journal:  Genetics       Date:  2015-03-27       Impact factor: 4.562

Review 7.  Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Authors:  Jonathan J Cherry; Dione T Kobayashi; Maureen M Lynes; Nikolai N Naryshkin; Francesco Danilo Tiziano; Phillip G Zaworski; Lee L Rubin; Jill Jarecki
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

8.  Transcriptome-wide Interrogation of the Functional Intronome by Spliceosome Profiling.

Authors:  Weijun Chen; Jill Moore; Hakan Ozadam; Hennady P Shulha; Nicholas Rhind; Zhiping Weng; Melissa J Moore
Journal:  Cell       Date:  2018-05-03       Impact factor: 41.582

9.  Evolutionary dynamics of U12-type spliceosomal introns.

Authors:  Chiao-Feng Lin; Stephen M Mount; Artur Jarmołowski; Wojciech Makałowski
Journal:  BMC Evol Biol       Date:  2010-02-17       Impact factor: 3.260

Review 10.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.